PINCHUK NICHOLAS T 4
4 · Snap-on Inc · Filed Feb 23, 2026
Research Summary
AI-generated summary of this filing
Snap-on (SNA) CEO Nicholas Pinchuk Exercises Options, Sells Shares
What Happened
Nicholas T. Pinchuk, Chairman, President & CEO (and Director) of Snap-on Inc., exercised 33,750 stock options (strike $168.70) on Feb 23, 2026, incurring an exercise cost of $5,693,625. On the same day he sold a total of 23,229 shares in multiple open‑market trades, generating approximately $8.9 million in proceeds (sales in tranches at weighted average prices between $381.36 and $388.68). This combination of an option exercise followed by share sales is routine and reflects a cashless/covering sale rather than an open‑market purchase.
Key Details
- Transaction date: February 23, 2026.
- Options exercised: 33,750 shares at $168.70 each — total exercise amount $5,693,625 (option fully vested).
- Shares sold: 23,229 shares in multiple trades, proceeds ≈ $8,905,028. Reported weighted‑average sale prices per tranche: $381.36, $382.19, $383.26, $384.22, $385.26, $386.35, $387.00, $388.68. (Trade price ranges shown in footnotes.)
- Footnotes: Transactions executed pursuant to a Rule 10b5‑1 plan adopted Nov 3, 2025; portions of the exercised shares were sold to cover exercise price and estimated tax withholding (cashless/withholding). Option exercise reported under Rule 16b‑3.
- Shares owned after the transactions: not specified in the provided filing excerpt.
- Filing timeliness: report date and filing date are both Feb 23, 2026 (appears timely).
Context
This was an option exercise with immediate sales of a portion of the underlying shares to cover the exercise cost and taxes (a common cashless exercise). The sales were executed under a prearranged 10b5‑1 plan, which is designed to provide a predetermined method for selling shares and reduce timing concerns. For retail investors, purchases by insiders can be more informative than routine, planned sales; here the activity appears consistent with exercising vested options and monetizing part of the award rather than a discretionary market‑timed sale.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-02-23$168.70/sh+33,750$5,693,625→ 869,791.436 total - Sale
Common Stock
[F1][F2]2026-02-23$381.36/sh−5,777$2,203,090→ 864,014.436 total - Sale
Common Stock
[F1][F3]2026-02-23$382.19/sh−4,538$1,734,395→ 859,476.436 total - Sale
Common Stock
[F1][F4]2026-02-23$383.26/sh−3,450$1,322,245→ 856,026.436 total - Sale
Common Stock
[F1][F5]2026-02-23$384.22/sh−3,933$1,511,154→ 852,093.436 total - Sale
Common Stock
[F1][F6]2026-02-23$385.26/sh−3,652$1,406,952→ 848,441.436 total - Sale
Common Stock
[F1][F7]2026-02-23$386.35/sh−1,000$386,346→ 847,441.436 total - Sale
Common Stock
[F1][F8]2026-02-23$387.00/sh−479$185,375→ 846,962.436 total - Sale
Common Stock
[F1][F9]2026-02-23$388.68/sh−400$155,471→ 846,562.436 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F11][F10]2026-02-23−33,750→ 101,250 totalExercise: $168.70Exp: 2027-02-09→ Common Stock (33,750 underlying)
- 867.704(indirect: By 401(k))
Common Stock
- 92,288
Stock Option (Right to Buy)
[F10]Exercise: $161.18Exp: 2028-02-15→ Common Stock (92,288 underlying) - 83,059
Stock Option (Right to Buy)
[F10]Exercise: $155.92Exp: 2029-02-14→ Common Stock (83,059 underlying) - 83,059
Stock Option (Right to Buy)
[F10]Exercise: $155.34Exp: 2030-02-13→ Common Stock (83,059 underlying) - 40,687
Stock Option (Right to Buy)
[F10]Exercise: $189.89Exp: 2031-02-11→ Common Stock (40,687 underlying) - 32,286
Stock Option (Right to Buy)
[F10]Exercise: $211.67Exp: 2032-02-10→ Common Stock (32,286 underlying) - 24,295
Stock Option (Right to Buy)
[F10]Exercise: $249.26Exp: 2033-02-09→ Common Stock (24,295 underlying) - 23,710
Stock Option (Right to Buy)
[F12]Exercise: $269.00From: 2025-02-15Exp: 2034-02-15→ Common Stock (23,710 underlying) - 18,925
Stock Option (Right to Buy)
[F12]Exercise: $339.73From: 2026-02-13Exp: 2035-02-13→ Common Stock (18,925 underlying) - 18,755
Stock Option (Right to Buy)
[F12]Exercise: $378.55From: 2027-02-12Exp: 2036-02-12→ Common Stock (18,755 underlying) - 5,114
Restricted Stock Units
[F13][F14]From: 2027-02-15Exp: 2027-02-15→ Common Stock (5,114 underlying) - 4,425
Restricted Stock Units
[F13][F14]From: 2028-02-13Exp: 2028-02-13→ Common Stock (4,425 underlying) - 4,515
Restricted Stock Units
[F13][F14]From: 2029-02-12Exp: 2029-02-12→ Common Stock (4,515 underlying) - 15,340
Performance Units
[F13][F15]→ Common Stock (15,340 underlying) - 13,275
Performance Units
[F13][F16]→ Common Stock (13,275 underlying) - 13,546
Performance Units
[F13][F17]→ Common Stock (13,546 underlying) - 26,242.585
Deferred Stock Units
[F13][F18]→ Common Stock (26,242.585 underlying)
Footnotes (18)
- [F1]The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025.
- [F10]Option fully vested.
- [F11]Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025.
- [F12]Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
- [F13]1 for 1.
- [F14]The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
- [F15]If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
- [F16]If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
- [F17]If the Company achieves certain goals over the 2026-2028 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
- [F18]Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.
- [F2]This transaction was executed in multiple trades at prices ranging from $380.74 to $381.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- [F3]This transaction was executed in multiple trades at prices ranging from $381.74 to $382.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- [F4]This transaction was executed in multiple trades at prices ranging from $382.74 to $383.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- [F5]This transaction was executed in multiple trades at prices ranging from $383.75 to $384.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- [F6]This transaction was executed in multiple trades at prices ranging from $384.75 to $385.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- [F7]This transaction was executed in multiple trades at prices ranging from $385.81 to $386.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- [F8]This transaction was executed in multiple trades at prices ranging from $386.84 to $387.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- [F9]This transaction was executed in multiple trades at prices ranging from $388.63 to $388.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.